Heart Attacks Despite Low LDL Cholesterol
Quick Facts
Why can heart attacks happen when LDL cholesterol is low?
LDL cholesterol is the most established modifiable risk factor for atherosclerotic cardiovascular disease. The Cholesterol Treatment Trialists' Collaboration, in a meta-analysis published in The Lancet in 2010, found that statin therapy reduced major vascular events by roughly one-fifth for each 1 mmol/L reduction in LDL cholesterol. Yet many patients who reach recommended targets still go on to have heart attacks, a phenomenon clinicians call residual cardiovascular risk.
Standard lipid panels report the cholesterol carried within particles, not the number or type of particles themselves. Two people with the same LDL cholesterol can carry very different numbers of atherogenic particles, and some particles transport more triglyceride than cholesterol. Researchers highlighted in a recent ScienceDaily report identified two kinds of fat-carrying particles that may contribute to risk even when LDL cholesterol appears healthy.
Which blood measures capture risk beyond LDL cholesterol?
Apolipoprotein B (apoB) counts the number of atherogenic particles because each carries one apoB molecule, and European guidelines recognize it as a useful secondary target. Remnant particles, rich in triglycerides, and lipoprotein(a), a largely inherited particle, are additional contributors that are not fully reflected by LDL cholesterol. Inflammation, high blood pressure, diabetes, smoking and kidney disease also shape the overall picture.
It is worth noting that this research does not suggest LDL lowering is ineffective. Rather, it argues for more refined risk assessment, particularly in people with premature disease, diabetes, metabolic syndrome or a strong family history. Whether targeting these particles will improve outcomes needs confirmation in clinical trials, as the history of cardiovascular drug development shows that lowering a biomarker does not always lower events.
What can patients do to lower residual cardiovascular risk?
Healthy eating patterns, regular physical activity, not smoking, weight management and good blood pressure and glucose control all lower cardiovascular risk independently of LDL cholesterol. Reducing refined carbohydrates and alcohol can help lower triglycerides in many people. Adherence to statins and other prescribed therapy remains essential, since benefit depends on sustained use.
Patients with a history of heart disease despite well-controlled LDL cholesterol may wish to ask their doctor whether measuring apoB, triglycerides or lipoprotein(a) is appropriate. Treatment decisions should be individualized, and no one should stop or alter medication on the basis of a single study.
Frequently Asked Questions
Not necessarily. LDL cholesterol is one important risk factor, but blood pressure, diabetes, smoking, family history, inflammation and other lipid particles also contribute.
It may be useful for people with high triglycerides, diabetes, metabolic syndrome or premature heart disease. Discuss with your clinician whether it is appropriate for you.
Yes. Diet, exercise, weight control and not smoking provide benefits that add to those of medication.
References
- Cholesterol Treatment Trialists' Collaboration. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. The Lancet. 2010.
- ScienceDaily. Why heart attacks can still happen even when bad cholesterol is low.
- World Health Organization. Cardiovascular diseases fact sheet.